In this clinical case, the tumor growth of more than 5 mm within a year is noteworthy and may be due to the presence of a germline FANCD2 mutation, which, along with other considerations, eventually determined subsequent treatment strategy for this patient, resulting in surgical intervention despite the small size of the tumor. The gene discussed is FANCD2; the disease is neoplasm.